These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11795678)

  • 1. Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome.
    Willemsen MA; Lutt MA; Steijlen PM; Cruysberg JR; van der Graaf M; Nijhuis-van der Sanden MW; Pasman JW; Mayatepek E; Rotteveel JJ
    Eur J Pediatr; 2001 Dec; 160(12):711-7. PubMed ID: 11795678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Lipoxygenase inhibition: a new treatment strategy for Sjögren-Larsson syndrome.
    Willemsen MA; Rotteveel JJ; Steijlen PM; Heerschap A; Mayatepek E
    Neuropediatrics; 2000 Feb; 31(1):1-3. PubMed ID: 10774987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy findings and clinical effects of montelukast sodium in a case with Sjögren-Larsson syndrome.
    Pirgon O; Aydin K; Atabek ME
    J Child Neurol; 2006 Dec; 21(12):1092-5. PubMed ID: 17156709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
    Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ
    Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sjögren-Larsson syndrome: 2 case reports].
    Galoin-Bertail C; Ogier de Baulny H; Wanders R; Schiff M; Bellavoine V; Mlika A; Benoist G; Baruteau J
    Arch Pediatr; 2012 Feb; 19(2):135-41. PubMed ID: 22192722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.
    Vural S; Vural A; Akçimen F; Bağci IS; Tunca C; Gündoğdu Eken A; Ruzicka T; Başak AN
    Int J Dermatol; 2018 Jul; 57(7):843-848. PubMed ID: 29704247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Long-Term Neurologic Efficacy of Zileuton in Sjögren-Larsson's Syndrome.
    Sarret C; Pichard S; Afenjar A; Boespflug-Tanguy O
    Neuropediatrics; 2017 Jun; 48(3):205-206. PubMed ID: 28388737
    [No Abstract]   [Full Text] [Related]  

  • 8. Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.
    Willemsen MA; Rotteveel JJ; de Jong JG; Wanders RJ; IJlst L; Hoffmann GF; Mayatepek E
    J Neurol Sci; 2001 Jan; 183(1):61-7. PubMed ID: 11166796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and 1H-MRS findings of three patients with Sjögren-Larsson syndrome.
    Nakayama M; Távora DG; Alvim TC; Araújo AC; Gama RL
    Arq Neuropsiquiatr; 2006 Jun; 64(2B):398-401. PubMed ID: 16917608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren-Larsson syndrome: definitive diagnosis on magnetic resonance spectroscopy.
    Poojary S; Shah M
    Cutis; 2017 Dec; 100(6):452-455. PubMed ID: 29360893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective inactivation of leukotriene B4 in patients with Sjögren-Larsson syndrome.
    Willemsen MA; de Jong JG; van Domburg PH; Rotteveel JJ; Wanders RJ; Mayatepek E
    J Pediatr; 2000 Feb; 136(2):258-60. PubMed ID: 10657837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral MRI and spectroscopy in Sjögren-Larsson syndrome: case report.
    Miyanomae Y; Ochi M; Yoshioka H; Takaya K; Kizaki Z; Inoue F; Furuya S; Naruse S
    Neuroradiology; 1995 Apr; 37(3):225-8. PubMed ID: 7603599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjogren-larsson syndrome: case report and review of neurologic abnormalities and ichthyosis.
    Dutra LA; de Aquino CC; Barsottini OG
    Neurologist; 2009 Nov; 15(6):332-4. PubMed ID: 19901712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of three siblings with Sjögren-Larsson syndrome.
    Altinok D; Yildiz YT; Seçkin D; Altinok G; Tacal T; Eryilmaz M
    Pediatr Radiol; 1999 Oct; 29(10):766-9. PubMed ID: 10525785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of white matter changes in the Sjögren-Larsson syndrome.
    Hussain MZ; Aihara M; Oba H; Ohtomo K; Uchiyama G; Hayashibe H; Nakazawa S
    Neuroradiology; 1995 Oct; 37(7):576-7. PubMed ID: 8570059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preterm birth in Sjögren-Larsson syndrome.
    Willemsen MA; Rotteveel JJ; van Domburg PH; Gabreëls FJ; Mayatepek E; Sengers RC
    Neuropediatrics; 1999 Dec; 30(6):325-7. PubMed ID: 10706028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
    Lossos A; Khoury M; Rizzo WB; Gomori JM; Banin E; Zlotogorski A; Jaber S; Abramsky O; Argov Z; Rosenmann H
    Arch Neurol; 2006 Feb; 63(2):278-80. PubMed ID: 16476818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do you know this syndrome? Sjogren-Larsson syndrome.
    Benez MD; Fontenelle E; Tozzi BB; Presotto C
    An Bras Dermatol; 2010; 85(6):951-3. PubMed ID: 21308331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
    Liu MC; Dubé LM; Lancaster J
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.